Skip to content
This search input has a predictive search function. When 3 letters or more are entered, a number of predictive results appear in a dropdown. Use arrow keys to navigate and use the enter key to go to the page highlighted.
    RENEW JOIN
    Dashboard

    Search Results

    331 Results

    Non-Emergency Involuntary Medication for Mental Disorders in U.S. Jails

    Psychiatrists who work in jail settings will encounter patients for whom the administration of non-emergency involuntary medication is clinically indicated for the stabilization of their serious mental illness. This resource document is intended to guide psychiatrists in decision-making about non-emergency involuntary psychiatric medication administration in U.S. jails by providing background information and highlighting issues for consideration.

    Safe Consumption Facilities

    In 2019, there were nearly 72,000 U.S. overdose deaths, a new record high. Most of these overdose deaths involved opioids, with rising involvement of fentanyl and fentanyl analogues, which are increasingly found in street heroin and other opioids and often without the knowledge of the user. Even more concerning, it appears that the coronavirus pandemic is further worsening the overdose crisis.1 In the context of this ongoing crisis, psychiatrists must be aware of the full range of policy, organi

    Marijuana as Medicine

    The medical use of marijuana has received considerable attention as several states have voted to remove civil and criminal penalties for patients with qualifying conditions. Yet, on a national level, marijuana remains a schedule I substance under the Controlled Substances Act (CSA), the most restrictive schedule enforced by the Drug Enforcement Administration (DEA) (1). The Food and Drug Administration (FDA), responsible for approving treatments after appropriate and rigorous study, addit

    Advocacy Teaching in Psychiatry Residency Training Programs

    Advocacy, generically defined as the active support for a particular cause, policy, or issue, is applicable to medicine and psychiatry as physicians’ responsible use of “their expertise and influence to advance the health and well-being of individual patients, communities, and populations” (Frank, 2005). Advocacy can be undertaken from within an organization or as an outside stakeholder, and it can focus on a single theme (e.g., Barber, 2008) or more generally on issues that relate to patient ne

    Harm Reduction

    Harm reduction is an evidence-based, standard-of-care approach that aims to reduce the harm that patients experience while using substances. It recognizes that the use of substances is an inherent component of substance use disorder and that some ways of using illicit substances are less harmful to patient medical, social, and psychological health than others.

    Across State Line Psychiatric Consultation Considerations Addendum to Risk

    In 2013, an APA Resource Document on “Risk Management and Liability Issues in Integrated Care Models” was developed.1 This document outlined liability issues in a new and emerging area of collaborative /integrated care. In this model psychiatrists’ expertise is leveraged through curbside consultations and caseload reviews to provide more effective care for mild to moderate behavioral health conditions in the primary care setting. With the advent of CPT codes for the Collaborative Care Model, the

    Religious/spiritual commitments and psychiatric practice

    Psychiatrists should maintain respect for their patients' commitments (values, beliefs and worldviews). a. It is useful for clinicians to obtain information on the religious/spiritual commitments of their patients so that they may properly attend to them in the course of assessment, formulation, and treatment. b. Empathy for the patient's sensibilities and particular commitments is essential. Conflicts, either within the patient or within the clinician-patient relationship should be handled with

    Load More

    Medical leadership for mind, brain and body.

    Join Today